Related Experiment Video
Updated: Feb 15, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Improvement of endothelial function by pitavastatin: a meta-analysis
Niki Katsiki1, Željko Reiner2, Eugenia Tedeschi Reiner3
1a Second Propedeutic Department of Internal Medicine, Medical School , Aristotle University of Thessaloniki, Hippocration Hospital , Thessaloniki , Greece.
Insights
Pitavastatin significantly improves flow-mediated dilation (FMD), a key indicator of endothelial function. This finding suggests pitavastatin therapy can enhance vascular health in patients with dyslipidemia.
Area of Science:
- Cardiovascular Research
- Pharmacology
- Medical Statistics
Background:
- Dyslipidemia is linked to endothelial dysfunction and elevated cardiovascular risk.
- Pitavastatin is known to improve lipid profiles and HDL function.
- Flow-mediated dilation (FMD) is a critical marker for endothelial health.
Purpose of the Study:
- To evaluate the impact of pitavastatin on flow-mediated dilation (FMD).
- To synthesize existing clinical trial data on pitavastatin's effect on endothelial function.
Main Methods:
- Systematic review and meta-analysis of clinical trials.
- Searched PubMed-Medline, Scopus, ISI Web of Knowledge, and Google Scholar.
- Employed a random-effects model for quantitative data synthesis.
Main Results:
- Included six studies with seven treatment arms.
- Demonstrated a significant increase in FMD with pitavastatin therapy (WMD: 2.45%, 95% CI: 1.31, 3.60, p < 0.001).
- The effect size remained robust in sensitivity analyses.
Conclusions:
- Pitavastatin therapy significantly enhances flow-mediated dilation (FMD).
- This suggests a beneficial effect of pitavastatin on endothelial function.
Objective:
Dyslipidemia is commonly associated with endothelial dysfunction and increased cardiovascular risk. Pitavastatin has been shown to reduce total and low-density lipoprotein cholesterol, to increase high-density lipoprotein (HDL)-cholesterol and improve HDL function. Furthermore, several trials explored its effects on flow-mediated dilation (FMD), as an index of endothelial function. The authors evaluated the effect of pitavastatin therapy on FMD.
Methods:
The authors performed a systematic review and meta-analysis of all clinical trials exploring the impact of pitavastatin on FMD. The search included PubMed-Medline, Scopus, ISI Web of Knowledge and Google Scholar databases. Quantitative data synthesis was performed using a random-effects model, with weighted mean difference (WMD) and 95% confidence interval (CI) as summary statistics.
Results:
Six eligible studies comprising 7 treatment arms were selected for this meta-analysis. Overall, WMD was significant for the effect of pitavastatin on FMD (2.45%, 95% CI: 1.31, 3.60, p < 0.001) and the effect size was robust in the leave-one-out sensitivity analysis.
Conclusion:
This meta-analysis of all available clinical trials revealed a significant increase of FMD induced by pitavastatin.
Related Concept Videos
Directing Effect of Substituents: meta-Directing Groups
Performing a Simple Data Analysis using MS-Excel Function
SUM: This function calculates the total sum of a range of values. It's the foundation for aggregating data, essential for determining overall trends and totals in datasets.
AVERAGE: It computes the mean value of a given set of numbers, providing a quick insight into the central...
meta-Directing Deactivators: –NO2, –CN, –CHO, –⁠CO2R, –COR, –CO2H
Improving Translational Accuracy
Improving Translational Accuracy
Functional Groups

